FDA To Impose New Pre-market Requirements On Infusion Pump Makers
This article was originally published in The Gray Sheet
Executive SummaryTo address widespread safety issues, FDA plans to put in place new requirements for external infusion pump 510(k) submissions, including asking device makers to provide an "assurance case" to document and support safety design specifications
You may also be interested in...
In response to a growing number of adverse events, FDA has asked infusion pump manufacturers to submit safety assurance cases to help understand the safety profile of their device when submitting a 510(K). But a final guidance appears to soften expectations that clinical studies always be performed to support clearance.
FDA is reviewing 600-plus comments on its draft human factors guidance and plans to "be much more specific" in the final version about the types of devices subject to the new data recommendations.